corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1086

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Heil E.
Frist Predicts Passage Of Medicare Reform Legislation ...
2003 Apr 29


Full text:

Senate Majority Leader Frist told the American Hospital Association today that the “legislative stars are lined up in an unprecedented way,” making passage more likely than ever of a comprehensive Medicare reform bill that includes a prescription drug benefit. Painting broad outlines of the plan that he predicted would clear the Senate Finance Committee and arrive on the Senate floor by the July Fourth recess, Frist said committee Republicans were still hammering out the details and would work with Democrats to craft a bipartisan bill.

The measure would allow seniors to keep their existing benefits and get access to a prescription drug card, he said. If seniors joined a new Medicare PPO, they could get access to a full-drug benefit. The plan would be an “assimilation of proposals from the past,” including the so-called tripartisan bill from last session, previous House proposals and the president’s proposed framework, Frist said. For example, the bill would adopt an element of the president’s proposal that would make PPOs regional, instead of focusing on individual counties. The measure will reach the Finance Committee by early June, he predicted. The House is likely to pass a bill “either in parallel, or slightly before” the Senate does, Frist said. “The political environment is right,” Frist told the hospital executives. “We have a president who has put together a … visionary plan for what Medicare should look like. We have a House that has three times passed a bill and will do so again this year. And now there is a U.S. Senate that is poised and ready to move.”

However, Frist cautioned that powerful forces were working against the passage of a drug benefit. The politics involved in the presidential race may complicate the chamber’s work, since as many as eight senators are running for office, he noted. He also complained of pervasive “obstructionism” from Democrats, citing the stalled nomination of Miguel Estrada to the federal appeals bench. “We have a unique opportunity today — a window of opportunity to strengthen and improve Medicare — but it is a narrow window.” Frist’s plan is likely to encounter resistance from some Senate Democrats, who are linking their fight against the proposed tax cuts to the Medicare debate. “The issue isn’t cost,” Sen. Edward Kennedy, D-Mass., told the AHA. “The issue is priorities. Health care for the American people is more important than a large, new tax break for millionaires.”

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963